Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |